Oppenheimer & CO Inc Horizon Therapeutics Public LTD CO Transaction History

Oppenheimer & CO Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$91.91 - $110.37 $597,415 - $717,405	-6,500 Closed	0 $0
Q2 2021 Aug 03, 2021	BUY	$86.24 - $95.92 $265,360 - $295,145	3,077 Added 89.89%	6,500 $609,000
Q1 2021 May 10, 2021	BUY	$71.83 - $95.48 $5,818 - $7,733	81 Added 2.42%	3,423 $315,000
Q4 2020 Feb 11, 2021	SELL	$67.0 - $84.39 $39,932 - $50,296	-596 Reduced 15.13%	3,342 $244,000
Q3 2020 Nov 13, 2020	BUY	$55.23 - $79.93 $2,485 - $3,596	45 Added 1.16%	3,938 $306,000

Q2 2020 Aug 11, 2020	BUY	$30.2 - $56.98 $117,568 - $221,823	3,893 New	3,893 $216,000

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Oppenheimer & CO Inc, based on Form 13F filings with the SEC.

Stay updated on Oppenheimer & CO Inc with notifications on news.